3 results
Primary objectives: To assess the ability of dabrafenib + trametinib treatment to downsize melanoma tumor masses to enable R0-resection. Secondary objectives: Recurrence free survival; time-to-next treatment, overall survival.
Primary Objective: to explore the prevalence of urinary concentration defects (NDI) in a Dutch population of lithium treated patients.Secondary Objectives: to determine the relation of the dDAVP test results with complaints (micturition history) and…
The primary objective of the study is to evaluate the effect of tiotropium + olodaterol FDCcompared to tiotropium monotherapy on the intensity of breathlessness during the 3min CSST.A secondary objective is to explore the relationship between…